Skip to content
+1 (949) 670-0403
Tisgenx
Tisgenx
Home
About Us
Technology
Products
Invengenx® – Cardiothoracic
Vascugenx™ – Vascular
Urogenx™ – Urology
Surgenx™ – General Surgery
Distributor
Resources
Events
News
Publications
Training
Contact Us
News
Correction: Circ_0001786 facilitates gefitinib resistance and malignant progression in non-small cell lung cancer via miR-34b-5p/SRSF1
Posted on
April 20, 2024
April 23, 2024
by